GENESIS Biomed has worked with the Xartec Salut network, led by CREB UPC, within the framework of the creation of new spin-off companies.

The collaboration consists of the development of the business plan and the financial plan of the projects selected by Xartec Salut, involving a total of 10 future spin-offs.

Within the framework of the Venture Builder Programme, a mechanism promoted by Xartec Salut to accelerate the creation of spin-off companies, GENESIS Biomed has collaborated during the years 2021 and 2022 in the preparation of the business plans of 10 projects from the Xartec Salut network with the greatest potential for the creation of a spin-off.

Through this work, GENESIS Biomed has carried out, for each project, a preliminary study of its degree of maturity and the key points to be taken into account in the preparation of the respective business plans. We have worked on aspects such as market analysis and positioning with respect to the main competitors, deals (licenses, M&A and investment rounds) most comparable to each project, the analysis of the IP strategy, the regulatory development plan, the business model and commercial plan, the human resources strategy and finally, the financial plan.

In the words of Josep Lluís Falcó, CEO of GENESIS Biomed “through this collaboration with Xartec Salut, GENESIS Biomed reinforces its commitment to research groups with an entrepreneurial spirit, acting as a facilitator for the development of the business plan, constitution and raising seed capital necessary to start the life cycle of each spin-off”.

“Xartec Salut has selected 12 innovations from the network with a high social and economic impact. Through the Venture Builder programme, we have generated tools to validate the projects and accelerate the creation of the spin-off. The founding team has been provided with business training and specialised consultancy in: business (GENESIS Biomed), legal, regulatory, intellectual property, market access, as well as individualised strategic mentoring,” says Berta Borràs, head of promotion and management of the network.

About Xartec Salut

Xartec Salut is a leading research and innovation network led by the Centre for Research in Biomedical Engineering (CREB) of the UPC, which is made up of 47 research groups in Catalonia belonging to 17 institutions (universities, hospitals and technology centres). Its aim is to catalyse R&D&I in the field of Health Technologies in Catalonia, promoting the exchange of knowledge, the creation of innovative companies and offering new tools for technology transfer. The project is co-financed by the European Union through the European Regional Development Fund (ERDF). www.xartecsalut.com 

About GENESIS Biomed

GENESIS Biomed is a biomedical health sector consultancy specialised in providing consultancy services in the genesis and early stages of the life cycle of biomedical spin-offs and start-ups, entrepreneurs and research centres.

Based on its experience, GENESIS Biomed helps entrepreneurs and researchers to shape their business plan and supports them in the process of raising private funds. GENESIS Biomed has raised 67 million euros in the last few years in 19 investment rounds.

GENESIS Biomed specialises in the biopharmaceutical, biotechnology, medical device, in vitro diagnostic, nutraceutical and cosmetic sectors. With more than 20 years of experience in the healthcare sector, GENESIS Biomed was founded in May 2017, and is located in the Barcelona Science Park and Madrid city centre.

For more information visit: https://genesis-biomed.com/